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Orphan nuclear receptor Nur77 
affects cardiomyocyte calcium 
homeostasis and adverse cardiac 
remodelling
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Maarten M. G. van den Hoogenhof3, Farid Meggouh1, Esther E. Creemers3, Carol Ann 
Remme3, Antonius Baartscheer3, Robbert J. de Winter2, Carlie J. M. de Vries1, 
E. Karin Arkenbout2,6 & Vivian de Waard1
Distinct stressors may induce heart failure. As compensation, β-adrenergic stimulation enhances 
myocardial contractility by elevating cardiomyocyte intracellular Ca2+ ([Ca2+]i). However, chronic 
β-adrenergic stimulation promotes adverse cardiac remodelling. Cardiac expression of nuclear 
receptor Nur77 is enhanced by β-adrenergic stimulation, but its role in cardiac remodelling is still 
unclear. We show high and rapid Nur77 upregulation in cardiomyocytes stimulated with β-adrenergic 
agonist isoproterenol. Nur77 knockdown in culture resulted in hypertrophic cardiomyocytes. 
Ventricular cardiomyocytes from Nur77-deficient (Nur77-KO) mice exhibited elevated diastolic and 
systolic [Ca2+]i and prolonged action potentials compared to wild type (WT). In vivo, these differences 
resulted in larger cardiomyocytes, increased expression of hypertrophic genes, and more cardiac 
fibrosis in Nur77-KO mice upon chronic isoproterenol stimulation. In line with the observed elevated 
[Ca2+]i, Ca2+-activated phosphatase calcineurin was more active in Nur77-KO mice compared to 
WT. In contrast, after cardiac pressure overload by aortic constriction, Nur77-KO mice exhibited 
attenuated remodelling compared to WT. Concluding, Nur77-deficiency results in significantly altered 
cardiac Ca2+ homeostasis and distinct remodelling outcome depending on the type of insult. Detailed 
knowledge on the role of Nur77 in maintaining cardiomyocyte Ca2+ homeostasis and the dual role 
Nur77 plays in cardiac remodelling will aid in developing personalized therapies against heart failure.
Myocardial contractility and heart rate are increased in response to stimulation of cardiomyocyte 
β -adrenergic receptors by catecholamines, to enhance cardiac function on demand1. Different cardiac 
insults, such as cardiomyopathies, myocardial infarction and loss of contractile function due to elevated 
pressure, also lead to β -adrenergic receptor activation, which acts as a compensatory mechanism to main-
tain cardiac output1,2. If these insults persist however, chronic overstimulation of β -adrenergic receptors 
occurs, enhancing maladaptive myocardial remodelling, involving hypertrophy, fibrosis and cardiomyo-
cyte death, eventually impairing contractility and heart failure. The deleterious potency of β -adrenergic 
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overstimulation is demonstrated by improved clinical outcome after inhibition of β -adrenergic receptor 
activation by β -blockers, currently the first-line therapy for heart failure3. With a prevalence of more 
than 23 million heart failure patients worldwide, and 5- and 10-year survival rates of respectively 50% 
and 10%, heart failure is one of the leading causes of death in the Western world4. Hence, unravelling 
the molecular pathophysiology in the early stages of cardiac remodelling, before the onset of functional 
heart failure, is of great importance for the development of novel therapeutic strategies.
Activation of β -adrenergic Gs-protein-coupled receptors induces activation of signalling cascades, 
leading to larger intracellular calcium ([Ca2+]i) transients, necessary for enhanced contractility. Larger 
increases in [Ca2+]i will lead to stronger contractions5. In addition, [Ca2+]i homeostasis is essential to 
regulate excitation-contraction coupling, maintain electrophysiological balance, and control transcrip-
tional regulation by activating key enzymes such as Ca2+-calmodulin-activated phosphatase calcineu-
rin6. Consequently, altered cardiomyocyte Ca2+ homeostasis is an important characteristic of diseased 
myocardium and plays a central role in the pathophysiology of cardiac remodelling and heart failure7.
Orphan nuclear receptor Nur77, also known as NR4A1, NGFI-B or TR3, is an immediate-early gene 
which is involved in cellular stress responses, metabolism, proliferation, differentiation and apoptosis 
in various cell types. In vascular disease, we and others have shown that Nur77 inhibits smooth mus-
cle proliferation8,9, macrophage accumulation10,11, pro-inflammatory macrophage polarization10–13, lipid 
loading/foam-cell formation13, and matrix metalloproteinase production9. Together with the promotion 
of a contractile phenotype in smooth muscle cells8,9, enhanced endothelial cell survival and endothelial 
cell-driven angiogenesis14, Nur77 has been attributed an atheroprotective role in the arterial vessel wall. 
At present, the role of Nur77 in the heart is less clear. Nur77 has been shown to mediate cardiomy-
ocyte apoptosis upon oxidative stress15 and in response to angiotensin II-induced pressure overload, 
Nur77-deficient (Nur77-KO) mice and rats with cardiac-specific Nur77 knock-down exhibit attenuated 
adverse cardiac remodelling16. However, after myocardial infarction, Nur77-KO mice were shown to 
present worsened outcome17. Together these reports imply a dual role for Nur77 in cardiac disease. 
Interestingly, β -adrenergic stimulation has been shown to significantly up-regulate Nur77 expression in 
the heart18 implying a role for Nur77 in β -adrenergic overstimulation-induced cardiac remodelling. Very 
recently, it was shown that Nur77 overexpression in murine hearts could attenuate hypertrophy after 
β -adrenergic overstimulation19. Here, we assess the effect of Nur77 deficiency on calcium homeostasis 
in cardiomyocytes, in cardiac remodelling induced by chronic β -adrenergic stimulation, and in relation 
to cardiac pressure overload by transverse aortic constriction (TAC).
Results
Nur77 expression in the healthy heart and isoproterenol-challenged cardiomyocytes. Nur77 
is rapidly and highly expressed in many tissues upon various stimuli. However, as shown on multi-tissue 
Northern blots, endogenous Nur77 expression is most pronounced in healthy human heart and skeletal 
muscle (Fig. 1a). Given that NR4A mRNA expression in whole hearts is increased by β -adrenergic stimu-
lation18,19, we assessed expression of Nur77, Nurr1 and NOR-1 in neonatal rat cardiomyocytes (NRVMs) 
upon β -adrenergic stimulation. After 1 h of stimulation with β -adrenergic agonist isoproterenol, gene 
expression of all three NR4A family members was robustly increased compared to PBS-stimulated 
cells, however Nur77 was expressed to the highest extent amongst all NR4A family members (Fig. 1b). 
Expression of all NR4A mRNAs was reduced back to control levels after 3 h of isoproterenol stimulation 
(Supplementary Fig. S1). Nuclear Nur77 protein is observed in healthy murine cardiomyocytes and its 
expression was markedly enhanced after 1 h and 3 h of isoproterenol stimulation (Fig.  1c). This high 
and rapid induction of Nur77 upon isoproterenol stimulation suggests a prominent role for Nur77 in 
the heart’s response to adrenergic stimulation. To see whether this has pathological implications, we 
assessed isoproterenol-induced cardiomyocyte hypertrophy upon Nur77 knockdown. Transfection with 
Nur77-specific siRNA (siNur77) resulted in markedly down-regulated Nur77 mRNA expression, and it 
significantly inhibited the observed isoproterenol-induced Nur77 mRNA upregulation when compared 
to control-transfected (siCon) cells (Fig. 1d). Interestingly, Nur77 knockdown in unstimulated NRVMs 
already resulted in significantly larger cardiomyocytes than siCon-transfected cells (Fig. 1d). Upon iso-
proterenol stimulation, siNur77 and siCon-transfected NRVMs significantly increased in size. Again, the 
siNur77-transfected NRVMs were significantly larger than siCon NRVMs, showing that reduced Nur77 
induces a hypertrophic response in isolated cardiomyocytes.
Nur77-KO cardiomyocytes exhibit elevated [Ca2+]i and prolonged action potentials. As Ca2+ 
is the key effector of adrenergic signalling, we analysed [Ca2+]i transients in adult wild type (WT) and 
Nur77-KO cardiomyocytes in the absence or presence of the synthetic adrenergic agonist isoproter-
enol or the native adrenergic agonist norepinephrine. Already at baseline, Nur77-KO cardiomyocytes 
exhibited significantly larger [Ca2+]i transient amplitudes compared to WT cells, a difference which was 
preserved upon stimulation with increasing concentrations of either isoproterenol or norepinephrine 
(Fig. 2a). The relative amplitude increase upon adrenergic stimulation did not significantly differ between 
WT and Nur77-KO cardiomyocytes (Fig.  2b). Interestingly, basal diastolic [Ca2+]i concentrations were 
significantly elevated in Nur77-KO cardiomyocytes compared to WT cells, yet without differences in the 
time to peak and decay time of the [Ca2+]i transient (Fig.  2c). Thus, Nur77-KO cardiomyocytes seem 
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Figure 1. Isoproterenol increases Nur77 expression in cardiomyocytes and Nur77 knockdown enhances 
isoproterenol-induced cardiomyocyte hypertrophy. (a) Northern blot analysis of Nur77 expression in 
healthy human tissues. Heart and skeletal muscle exhibited highest endogenous Nur77 expression relative to 
loading control β -actin. Blots have been prepared under the same experimental conditions.  
(b) Significantly up-regulated NR4A gene expression in NRVMs after 1 h of isoproterenol (ISO) stimulation 
(n = 3), with Nur77 mRNA levels showing highest abundance. (c) Representative example of nuclear Nur77 
protein expression in cardiomyocytes of healthy WT C57Bl/6 mice as assessed by immunohistochemistry. 
Photomicrograph shown at 200× magnification. Nur77 protein expression is significantly enhanced in 
nuclei of NRVMs after isoproterenol stimulation for 1 and 3 h (n = 4). (d) NRVMs are significantly larger 
after siRNA-mediated Nur77 knockdown (siNur77) compared to control-transfected (siCon) cells under 
both control conditions and 48 h of isoproterenol stimulation, as assessed by α -Actinin staining in > 250 
cells per group (n = 3). Photomicrographs are shown at 200× magnification. Boxplots represent median, 
inter-quartile range and minimum/maximum values; bars represent mean + SEM; *p < 0.05, **p< 0.01, 
***p < 0.001.
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equally responsive to acute adrenergic stimulation when compared to WT, however exhibit significantly 
larger [Ca2+]i transients and elevated diastolic [Ca2+]i levels under basal conditions.
To further characterize Nur77-KO cardiomyocytes, we measured if the changes in [Ca2+]i influence 
the electrophysiological properties of these cells. Figure  3a,b, show typical action potentials (APs) and 
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Figure 2. Nur77-KO cardiomyocytes exhibit altered [Ca2+]i homeostasis. Adult cardiomyocytes were 
isolated from at least 3 different WT and Nur77-KO mice. Baseline measurements were performed in WT 
(n = 31) and Nur77-KO (n = 33) cardiomyocytes, of which 14–19 per group were subsequently stimulated 
with isoproterenol (ISO) or norepinephrine (NOR). (a) Representative [Ca2+]i transient and amplitude 
quantification. [Ca2+]i transient amplitudes were significantly higher in Nur77-KO cardiomyocytes at 
baseline and upon stimulation with either isoproterenol or norepinephrine. (b) Amplitude increase relative 
to baseline upon adrenergic stimulation did not differ between WT and Nur77-KO cardiomyocytes.  
(c) Basal diastolic [Ca2+]i concentration was significantly elevated in Nur77-KO cardiomyocytes, while 
transient peak and decay times were unchanged compared to WT cardiomyocytes. Data presented as 
mean± SEM; *p < 0.05, **p < 0.01.
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average AP properties, respectively, measured at 6 Hz. No differences in resting membrane potential 
(RMP) and AP amplitude (APA) were observed between WT and Nur77-KO cardiomyocytes. Also, max-
imal AP upstroke velocity (dV/dtmax), a measure of sodium channel availability, did not differ between 
the groups. This is in line with unaltered ex vivo conduction parameters observed between isolated, 
Langendorff-perfused, WT and Nur77-KO hearts (Supplementary Fig. S2). While no significant differ-
ences in AP duration at 20% and 50% of repolarization (APD20 and APD50, respectively) were observed, 
Nur77-KO APs display a significantly longer duration at 90% repolarization (APD90) compared to WT. 
Specifically a 24% lengthening of the APD90 was observed. Prolonged APs are in line with the trend 
towards prolonged ex vivo effective refractory period (ERP; p = 0.06) of Nur77-KO hearts. Significant 
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Figure 3. Nur77-KO cardiomyocytes exhibit prolonged action potentials. Action potential (AP) 
measurements were performed in WT (n = 20) and Nur77-KO (n = 18) cardiomyocytes isolated from 3 mice 
of each group. (a) Representative APs at 6 Hz. Inset shows the maximal AP upstroke velocity (dV/dtmax). 
(b) Average AP characteristics at 6 Hz. No differences were observed in resting membrane potential (RMP), 
AP amplitude (APA) or AP duration (APD) at 20% and 50% repolarization. APD90 was significantly longer 
in Nur77-KO cardiomyocytes. (c) APD90 was significantly enhanced in Nur77-KO cardiomyocytes at all 
measured stimulation frequencies. Early after-depolarisations (inset; arrow) were observed only in a subset 
of Nur77-KO cardiomyocytes at 1 and 2 Hz. Data presented as mean ± SEM; *p < 0.05.
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changes in APD90 were evident at all measured stimulation frequencies (Fig. 3c). Interestingly, at a stim-
ulus frequency of 1 and 2 Hz, early after-depolarisations (EADs; Fig. 3c inset; arrow) were observed in 
22% of Nur77-KO cardiomyocytes, but never in WT cells (P ≤ 0.05, Fisher exact test). Taken together 
these data suggest a role for Nur77 in electrochemical Ca2+ homeostasis maintenance in cardiomyocytes.
Expression of cardiac Ca2+-handling-related genes. As Nur77 is a transcriptional regulator, we 
wondered if the altered Ca2+ homeostasis in Nur77-KO cardiomyocytes may be explained by differences 
on gene expression level. Thus, we analysed gene expression of adrenergic receptors and Ca2+-handling 
proteins in left ventricular lysates of healthy WT and Nur77-KO mouse hearts. Neither α - nor the 
major β -adrenergic receptor subtypes (adra1, arb1, adrb2) were expressed differentially in Nur77-KO 
left ventricles compared to WT (Fig. 4a), suggesting there is no obvious difference in endogenous cardiac 
adrenergic stimulation between the groups. Interestingly, only a significant down-regulation of serca2a 
gene expression was detected in Nur77-KO mice, while genes encoding for phospholamban (plb), the 
ryanodine receptor (ryr2), the L-type Ca2+ channel (cacnb2), the Na+/Ca2+ exchanger (ncx) and plasma 
membrane Ca2+ ATP-ase (pmca) did not differ significantly (Fig. 4b).
Nur77 deficiency aggravates isoproterenol-induced cardiac remodelling. Alteration of cardi-
omyocyte [Ca2+]i has long been implied as an important regulator of maladaptive cardiac remodelling 
and heart failure6, therefore we assessed the effect of Nur77 deficiency on the development of adverse 
cardiac remodelling in response to chronic β -adrenergic stimulation. We implanted osmotic minipumps, 
delivering a relatively high dose of isoproterenol for one week, in WT and Nur77-KO mice. During the 
experiment, 3 out of 16 isoproterenol-treated Nur77-KO mice died, two of which had no apparent car-
diac tissue damage and one mouse exhibiting cardiac rupture (tamponade). All isoproterenol-treated WT 
mice (n = 16) and control Nur77-KO and WT mice (n = 9 per group) survived the experiment. Although 
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Figure 4. Gene expression patterns of adrenergic receptors and Ca2+ -handling proteins in WT and 
Nur77-KO hearts. RT-PCR analysis of ventricular lysates from WT and Nur77-KO mice (n = 6 each). 
(a) Expression of α - and β -adrenergic receptors did not differ between WT and Nur77-KO. adra1: 
α 1-adrenergic receptor; adrb1: β 1-adrenergic receptor; adrb2: β 2-adrenergic receptor (b) serca2a was 
significantly down-regulated in Nur77-KO mice, while all other assessed Ca2+ -handling proteins were not 
differentially expressed. serca2a: sarco/endoplasmic Ca2+ ATPase; plb: phospholamban; ryr2: ryanodine 
receptor 2; cacnb2: l-type Ca2+ channel; ncx: Na+/Ca2+ exchanger; pmca: plasma membrane Ca2+ ATPase. 
Boxplots represent median, inter-quartile range and minimum/maximum values; **p < 0.01.
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no significant changes in cardiac function were apparent after 1 week (Supplementary Fig. S3), the effec-
tiveness of this short-term hypertrophy model is demonstrated by a higher heart weight to tibia length 
(HW/TL) ratio in the isoproterenol-treated mice compared to their controls (Fig. 5a). Furthermore, the 
surviving Nur77-KO mice exhibited a trend (p = 0.06) towards a higher HW/TL ratio when compared 
to the WT mice. Validation of the cardiomyocyte surface area showed that cardiomyocytes were signif-
icantly larger in isoproterenol-treated mice compared to the controls. In line with Nur77 knockdown in 
cultured rat cardiomyocytes, isoproterenol-treated Nur77-KO cardiomyocytes were significantly larger 
than in isoproterenol-treated WT mice (Fig. 5b).
Assessment of the hypertrophic foetal gene program20, revealed that all measured genes were 
up-regulated in ventricular lysates of isoproterenol-treated mice compared to the untreated controls 
(Fig.  5c). In addition, skeletal alpha actin (acta-1) and β -myosin heavy chain (myh7) were expressed 
significantly higher in isoproterenol-treated Nur77-KO mice, while there was no difference in atrial and 
brain natriuretic factor (anp and bnp) expression. It should be noted that both Acta-1 and Myh7 are 
involved in contractility, suggesting involvement of Nur77 in cardiomyocyte contractility.
Fibrosis is an important pathological feature associated with adverse cardiac remodelling2. In the 
isoproterenol-treated mice, already in the short time frame of one week, isoproterenol stimulation 
caused interstitial fibrosis in hearts of both WT and Nur77-KO mice, when compared to the control 
hearts (Fig.  5d). Upon quantification, a 3-fold induction in fibrosis was measured in the Nur77-KO 
mice (median 4.1%), as compared to WT mice (median 1.4%). As Nur77 has been shown to regulate 
apoptosis in a variety of cells, including cardiomyocytes15, we assessed apoptotic cells in the heart after 
isoproterenol-induced remodelling. However, apoptotic cardiac cells were only observed in a fraction of 
the mice within each group, showing no difference between WT and Nur77-KO (Supplementary Fig. S3).
Protein phosphatase calcineurin is activated by sustained [Ca2+]i elevation21 and calcineurin activa-
tion has long been implied as a sufficient inducer of hypertrophic signalling in heart22. We hypothesized 
that the elevated [Ca2+]i in Nur77-KO cardiomyocytes may lead to higher activation of calcineurin and 
therefore may explain the enhanced remodelling observed in Nur77-KO mice. Therefore, we assessed 
calcineurin activity in left ventricular lysates. Indeed, calcineurin activity is already 2-fold higher in con-
trol Nur77-KO mice compared to WT (Fig. 5e). While calcineurin activity is significantly enhanced in 
WT hearts after isoproterenol stimulation as expected, calcineurin was interestingly not further increased 
in Nur77-KO mice.
Taken together, these results demonstrate a cardioprotective role for Nur77 upon chronic β -adrenergic 
stimulation. However, how do these data relate to the existing Nur77 data on cardiac remodelling?
Nur77 deficiency attenuates TAC-induced cardiac remodelling. Very recently, it was shown that 
local adenoviral overexpression of Nur77 in murine hearts could reduce hypertrophy after β -adrenergic 
stimulation with isoproterenol19, supporting our findings. In two different models of pressure over-
load, by chronic angiotensin-II infusion16 or TAC15, up-regulation of cardiac Nur77 expression was 
observed. Interestingly, cardiac remodelling by angiotensin-II-induced pressure overload was attenuated 
in Nur77-KO mice16. As this is in contrast with the observations after β -adrenergic overstimulation, we 
subjected WT and Nur77-KO mice to TAC-induced cardiac pressure overload, to establish whether the 
effect of Nur77 deficiency is dependent on the type of cardiac stressor. In line with the angiotensin-II 
model, cardiac pressure overload in Nur77-KO mice led to attenuated adverse cardiac remodelling com-
pared to WT after 28 days of TAC. Survival was equal between the two groups; 1 out of 13 WT and 1 out 
of 12 Nur77-KO mice died during the experiment. Nur77-KO mice showed a trend towards enhanced 
cardiac function (p = 0.10 ejection fraction, p = 0.08 fractional shortening) assessed by echocardiog-
raphy (Supplementary Fig. S4). In addition to cardiac function, left ventricular weight/TL ratio was 
lower in Nur77-KO mice compared to WT (Fig. 6a), suggesting reduced hypertrophy. Indeed, the mean 
cardiomyocyte surface area was significantly smaller in Nur77-KO mice (Fig.  6b). Moreover, expres-
sion of anp, bnp, acta-1 and myh7 were all significantly lower in Nur77-KO ventricular tissue (Fig. 6c). 
As TAC induces cardiac pressure overload, we assessed perivascular and interstitial fibrosis separately. 
Interestingly, perivascular fibrosis was significantly higher in WT mice compared to Nur77-KO mice, 
whereas no significant difference was observed in interstitial collagen deposition (Fig.  6d). As in the 
isoproterenol model, no difference in the number of apoptotic cells in WT and Nur77-KO hearts was 
found after TAC (Supplementary Fig. S4).
In conclusion, our data demonstrate that Nur77 plays a detrimental role in the heart upon TAC-induced 
pressure overload, in contrast to its role in isoproterenol-induced cardiac remodelling. Taking together 
our data on Nur77 in the heart with existing data, we propose the following scheme on the function of 
Nur77 in different cardiac insult models, leading to heart failure (Fig. 6e).
Discussion
Essential roles for Nur77 have been demonstrated regarding atherosclerosis10,11,23, cancer24 and metabolic 
disease25. However, knowledge on the functional role of Nur77 in the cardiac setting is limited. The 
abundant endogenous expression of the NR4A family of nuclear receptors, including Nur77, in healthy 
murine heart tissue was previously described by Myers et al.18. Here, we demonstrate that also in the 
healthy human heart, endogenous Nur77 expression is relatively high as compared to other tissues.
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Figure 5. Nur77-KO mice exhibit enhanced adverse cardiac remodelling after chronic β-adrenergic 
stimulation. WT (n = 16) and 13 surviving Nur77-KO mice were analysed after 1 week of chronic isoproterenol 
(ISO) infusion. (a) Heart weight/tibia length (HW/TL) ratio was higher after isoproterenol stimulation and 
further increased in Nur77-KO mice compared to WT mice. Tibia length did not differ between WT and 
Nur77-KO mice. (b) Cardiomyocyte cross-sectional area was significantly larger in isoproterenol-treated 
Nur77-KO mice compared to treated WT mice, as assessed by fluorescent wheat germ agglutinin staining 
in > 75 cells per heart. Photomicrographs are shown at 630× magnification. (c) RT-PCR analysis showed 
significant up-regulation of foetal gene expression after isoproterenol treatment. Nur77-KO mice exhibited a 
significant increase in acta1 and myh7 after isoproterenol, when compared to WT. anp: atrial natriuretic peptide; 
bnp: brain natriuretic peptide; acta1: α 1 skeletal actin; myh7: β -myosin heavy chain. (d) Collagen deposition 
was assessed by Masson’s Trichrome staining assessed by quantitative morphometry, photomicrographs are 
shown at 50× magnification. The left ventricle and septum of Nur77-KO mice was affected stronger by 
interstitial fibrosis (blue) after isoproterenol than WT mice. (e) Calcineurin phosphatase activity is significantly 
higher in myocardium of control Nur77-KO mice. After chronic isoproterenol stimulation, calcineurin activity 
is significantly enhanced in WT hearts, while it does not further increase in Nur77-KO mice compared to 
Nur77-KO control mice (n = 3–4 in each group). Boxplots represent median, inter-quartile range and minimum/
maximum values; bars represent mean+ SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
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A number of studies describe enhanced expression of Nur77 in the diseased heart15–17,19. Transient 
up-regulation of cardiac Nur77 mRNA and protein has been shown in animal models of pressure-overload 
induced by TAC15, chronic angiotensin-II infusion16, as well as in ischemia following myocardial infarc-
tion15. Nur77-KO mice and rats with cardiac-specific Nur77 knock-down exhibited attenuated cardiac 
Figure 6. Attenuated pressure overload-induced adverse cardiac remodelling in Nur77-KO mice. WT 
(n = 12) and Nur77-KO (n = 11) mice were analysed after 28 days of TAC. (a) Left ventricle/tibia length 
(LV/TL) ratio was significantly lower in Nur77-KO mice after TAC than in WT mice. Tibia length did 
not differ between WT and Nur77-KO mice. (b) Cardiomyocytes from Nur77-KO mice were significantly 
smaller compared to cardiomyocytes from WT mice, as assessed by fluorescent wheat germ agglutinin 
staining in > 75 cells per heart. Photomicrographs are shown at 630× magnification. (c) Foetal gene 
expression after TAC was significantly down-regulated in Nur77-KO mice, as assessed by RT-PCR. anp: 
atrial natriuretic peptide; bnp: brain natriuretic peptide; acta1: α 1 skeletal actin; myh7: β -myosin heavy 
chain. (d) Collagen deposition as assessed by Masson’s Trichrome staining, photomicrograph shown at 100× 
magnification. Significantly less perivascular fibrosis was present in Nur77-KO mice compared to WT, while 
areas of interstitial fibrosis were not different. *p < 0.05, **p < 0.01. (e) Proposed mechanism for the role 
of Nur77 in cardiac remodelling induced by different insults. ISO: isoproterenol; TAC: transverse aortic 
constriction; AngII: angiotensin II; LAD: left anterior descending coronary artery; ROS: reactive oxygen 
species.
www.nature.com/scientificreports/
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remodelling after chronic angiotensin-II infusion. Angiotensin-II induces cardiac hypertrophy by 
increasing systemic blood pressure in conjunction with increased signalling of the angiotensin-II type 
I receptor on cardiomyocytes26. Nur77 is considered detrimental in this model by activating mTORC1, 
leading to cardiac hypertrophy by enhancement of protein synthesis, cardiomyocyte growth and reactive 
oxygen species (ROS) production16. In cultured cardiomyocytes, a ROS challenge was shown to cause 
Nur77 translocation to mitochondria, causing cytochrome c release and subsequent apoptosis15. In the 
same study, mitochondrial translocation of Nur77 was observed after ischemia/reperfusion injury in the 
heart. In our murine studies, apoptosis did not seem to play a key role in the observed pathologies. In 
contrast, Hilgendorf et al.17 observed after myocardial infarction, that Nur77-KO mice exhibit enhanced 
adverse cardiac remodelling with increased inflammation, fibrotic scar size and ventricular dysfunction17.
Rapid up-regulation of Nur77 in whole mouse hearts was previously reported after a single intra-
peritoneal injection of isoproterenol18,19. Here, we show that both Nur77 mRNA and nuclear protein are 
rapidly and highly up-regulated in isolated cardiomyocytes in response to isoproterenol stimulation. To 
assess Nur77 function, knockdown of Nur77 in cultured cardiomyocytes revealed that Nur77 deficiency 
caused a hypertrophic response, which was further enhanced upon isoproterenol stimulation. Very 
recently, Yan et al.19 demonstrated, in accordance with our data, attenuated cardiomyocyte hypertrophy 
after isoproterenol stimulation when overexpressing Nur77. In addition, adverse cardiac remodelling in 
mice was reduced by cardiac-specific Nur77 overexpression. They reveal an interaction of Nur77 with 
the pro-hypertrophic transcription factors NFATc3 and GATA-4, of which NFATc3 is regulated by cal-
cineurin. In our study, we show that the adverse cardiac remodelling we observe in Nur77-KO mice after 
chronic isoproterenol treatment, may be initiated by elevated cardiomyocyte [Ca2+]i and downstream 
calcineurin, since diastolic [Ca2+]I and [Ca2+]i transient amplitudes are already significantly elevated 
in unstimulated Nur77-KO cardiomyocytes and calcineurin activity is enhanced in healthy Nur77-KO 
myocardium.
Elevation of diastolic [Ca2+]i is a well-known feature of overtly failing cardiomyocytes, accompanied 
by decreased [Ca2+]i transient amplitudes and prolonged decay times27. This diastolic Ca2+ accumula-
tion is usually associated with diminished sarcoplasmic sequestration, often by lowered Serca function28. 
Indeed we observed significantly lower Serca2a mRNA expression in Nur77-KO hearts. However, as 
transient decay times were not prolonged and amplitudes were not diminished, Ca2+ sequestration does 
not seem to be impaired in Nur77-KO cardiomyocytes. To shed light on the mechanism behind the 
elevated diastolic and systolic [Ca2+]i in Nur77-KO cardiomyocytes, the different mechanisms which 
facilitate cytosolic Ca2+ influx and efflux must be assessed. Higher sarcoplasmic Ca2+ load, increased 
sarcoplasmic Ca2+ leak due to enhanced open probability of RyR channels, increased L-type Ca2+ cur-
rent, decreased expression or enhanced reverse mode activity of NCX and cytosolic Na+ accumulation 
have all been shown to interplay with elevated diastolic and systolic Ca2+ (as reviewed previously29). 
Electrophysiological characterization revealed that cardiac conduction was unaffected in Nur77-KO 
hearts, but Nur77-KO cardiomyocytes displayed prolonged APs and EADs. Both prolonged APs and 
EADs may form pro-arrhythmic substrates30, possibly explaining the two dead Nur77-KO mice in our 
isoproterenol experiment, which did not reveal an obvious cause of death. Prolonged APs and EADs may 
occur upon reduction of repolarization reserve by either increased L-type Ca2+ current or reduced potas-
sium (K+) current, or a combination of both31,32. Nur77 may regulate the K+ channel, IK,slow2, encoded 
by the Kv2.1 gene (kcnb1), since a mutation in a potential Nur77 DNA-binding site in the kcnb1 pro-
moter reduced its activity33. Decreased kcnb1 levels have been reported in cardiac disease34,35. On the 
other hand, an increase in L-type Ca2+ current in Nur77-KO cardiomyocytes would be in line with the 
larger [Ca2+]i transient amplitudes. In neuronal cells, K+Cl−-induced membrane depolarization enhances 
[Ca2+]i rises with subsequent activation of calcineurin36,37. Downstream of calcineurin, cAMP response 
element binding protein (CREB) subsequently stimulates expression of Nur7738. Expression of NR4A 
family member Nurr1 is also regulated by calcineurin and this induction was inhibited upon L-type 
Ca2+ channel blockade39. Taken together, we hypothesize that Nur77 may exert a feedback mechanism 
on [Ca2+]i elevations and calcineurin activity.
In line with our isoproterenol experiment, Nur77-KO mice exhibited a worsened outcome after 
myocardial infarction17. However, this effect was largely attributed to deficiency of reparative Ly6C-low 
monocytes in the Nur77-KO mice17, while potential changes in cardiomyocytes were not taken into 
account. Given that Nur77 is essential for the development of Ly6C-low monocytes40 and that these cells 
are instrumental to repair cardiac damage and resolve fibrosis41, the enhanced cardiac damage observed 
in the Nur77-KO mice in our isoproterenol model may partially be explained by Ly6C-low monocyte 
deficiency. Interestingly, the absence of Ly6C-low monocytes does not seem to affect cardiac damage after 
TAC in a negative manner, supporting the notion that Nur77 is also important in cardiac cells.
The Nur77-KO cardiomyocyte phenotype appears unfavourable, yet, challenging Nur77-KO mice 
with different cardiac stressors resulted in opposite remodelling outcomes. In line with published data16, 
we also observed that Nur77 has an adverse function in cardiac remodelling caused by pressure over-
load, while we reveal a protective role for Nur77 in cardiac remodelling caused by β -adrenergic over-
stimulation. While activation of β -adrenergic signalling may be present as a compensatory mechanism 
upon pressure overload, the role of Nur77 seems to be dependent on the dominant cardiac stressor. 
We hypothesize that increased [Ca2+]i availability in Nur77-KO cardiomyocytes preserves contractility, 
which may compensate for the increased pressure, leading to improved outcome after TAC. Chronic 
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isoproterenol stimulation modulates Ca2+ handling by increasing cardiomyocyte AP duration, enhancing 
reverse Na+/Ca2+-exchange and decreasing K+ current density (reviewed in42). In Nur77-KO cardiomyo-
cytes, where basal [Ca2+]i is already relatively high, we hypothesize that chronic β -adrenergic stimulation 
induces [Ca2+]i abnormalities more easily.
Since only limited changes were observed in cardiac function in both models as assessed by echo-
cardiography, our study contributes to the understanding of early stages of cardiac remodeling, when 
intervention to prevent the heart from eventual failure is still feasible.
In conclusion, we have shown for the first time that Nur77 deficiency leads to elevated intracellu-
lar Ca2+ levels and prolonged action potentials in cardiomyocytes and enhanced calcineurin activity in 
Nur77-KO hearts, however resulting in opposite cardiac remodelling outcome after different types of 
cardiac insults. Modulation of Nur77 may be a novel therapeutic target in managing adverse myocardial 
remodelling and heart failure, discriminating between cardiac stressors. Our study supports the assump-
tion that knowing the induction mechanism of cardiac remodelling in patients is crucially important 
before deciding on a therapeutic strategy.
Methods
Northern blot analysis. Human multiple tissue poly(A)+ RNA blots were purchased from 
CLONTECH (Palo Alto, CA, USA) and hybridized according to manufacturer’s protocol. Detection was 
performed using a fragment of human Nur77 cDNA (base pairs 864 to 1905) and the supplied human 
β -actin cDNA probe for normalisation.
Cell isolation and culture. Neonatal rat ventricular myocytes (NRVMs) were isolated as previously 
described43. In short, hearts from 1–3 day old Wistar rats were excised, atria were removed, and hearts 
were cut into 4–6 pieces. The pieces were left overnight to rotate at 4 °C in HBSS (Invitrogen, Carlsbad, 
CA, USA) containing 1 mg/ml trypsin (Affymetrix, Santa Clara, CA, USA). The next day, cells were 
dissociated using 1 mg/ml collagenase (Worthington, Lakewood, NJ, USA) in HBSS. Cells were collected 
and resuspended in M199 culture medium, supplemented with 1% HEPES, 1% NEAA, 2 mg/L vitamin 
B12, 3.5 g/L glucose, and antibiotics (all from Invitrogen), and pre-plated to separate myocytes from 
fibroblasts. After 2 hours, non-adherent cells were collected, counted and plated on fibronectin-coated 
plates. NRVMs were serum-starved for 24 h in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with penicillin/streptavidin (Invitrogen) before experiments.
Protein isolation and Western blotting. NRVMs were stimulated with 25 µm isoproterenol 
(Sigma-Aldrich, St. Louis, MO, USA) or equivalent volume of PBS for indicated time points. Nuclear 
protein was isolated from NRVMs using the NE-PER Nuclear and Cytoplasmic extraction kit (Thermo 
Scientific, Rockford, IL, USA) according to manufacturer’s protocol. Lysates were boiled, separated 
by SDS-PAGE and transferred onto PVDF membranes. After transfer, membranes were blocked with 
Odyssey blocking buffer (LI-COR, Lincoln, NB, USA) and incubated with anti-Nur77 (Santa Cruz, 
Dallas, TX, USA) and anti-H3 (Abcam, Cambridge, UK) for normalisation. Anti-rabbit IRDye800 was 
used as secondary antibody (LI-COR). Blots were scanned and quantified using the LI-COR Odyssey 
Infrared Imaging System.
Nur77 knockdown and NRVM size assessment. NRVMs were transfected with a final concentra-
tion of 175 nM Nur77 siRNA (SMARTpool, Dharmacon, Lafayette, CO, USA) or a non-targeting control 
siRNA for 6 h using Lipofectamine RNAiMAX (Invitrogen) according to manufacturer’s instructions. 
For assessment of Nur77 knockdown, NRVMs were cultured for 48 h after transfection and were sub-
sequently stimulated with 25 µm isoproterenol or equivalent volume of PBS for 1 h. For cell size exper-
iments, NRVMs were stimulated with 25 µm isoproterenol or PBS for 48 h after transfection. Cells were 
fixed with 4% paraformaldehyde (Roth, Karlsruhe, Germany) and stained with anti-α -Actinin antibody 
(Sigma Aldrich), Hoechst and anti-mouse AlexaFluor488-conjugated secondary antibody (Molecular 
Probes, Eugene, OR, USA). Size was measured in ≥ 250 Actinin-positive cells per group using ImageJ 
software (U.S. National Institutes of Health, Bethesda, Maryland, USA).
Mice. All animal housing, care and procedures were approved by the institutional Animal Experimental 
Committee for Animal Welfare in accordance with the Directive 2010/63/EU of the European Parliament. 
Mice used for cardiomyocyte isolations and experimental procedures are C57Bl/6 WT or Nur77-KO 
mice in C57Bl/6 background, all 10–12 week-old males.
[Ca2+]i transient measurements. Left ventricular cardiomyocytes from WT and Nur77-KO mice 
were isolated by enzymatic dissociation44 and loaded with fluorescent Ca2+ probe Indo-1-AM (Molecular 
Probes, Eugene, OR, USA) as described previously45. Using 4 Hz stimulation frequency, baseline [Ca2+]i 
was measured for 1 min, followed by measurements directly upon stimulation with increasing concentra-
tions of isoproterenol (Sigma) or norepinephrine (Centrafarm, Etten-Leur, The Netherlands).
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Action potential measurements. Action potentials were recorded in unstimulated, single cardio-
myocytes isolated from WT and Nur77-KO mice, by the amphotericin-perforated patch-clamp technique 
using an Axopatch 200B amplifier (Molecular Devices, USA) as described previously46.
Ex vivo assessment of cardiac conduction parameters. Atrio-ventricular and ventricular con-
duction parameters were investigated in isolated, Langendorff-perfused WT and Nur77-KO mice hearts 
using optical mapping, as described previously46.
Chronic isoproterenol stimulation in vivo. Osmotic minipumps (Alzet, Cupertino, CA, USA) were 
implanted subcutaneously in WT or Nur77-KO mice. The procedure was performed under isoflurane 
anaesthesia (4% isoflurane for induction, 2.5% isoflurane and O2 for maintenance of anaesthesia; Baxter, 
Illinois, United States) with subcutaneously-administered Carprofen (4 mg/kg) as a local analgetic. The 
osmotic minipumps continuously released isoproterenol (Sigma) dissolved in saline, in a dose of 60 mg/
kg/day. Control mice received minipumps containing saline only. After 7 days the mice were euthanized 
through a lethal dose of intraperitoneal-injected ketamine (238 mg/kg)/xylazine (102 mg/kg). Prior to 
and 6 days after implantation of the osmotic minipumps, transthoracic echocardiography was performed 
in isoflurane-anaesthetized mice (4% isoflurane for induction, 2.5% isoflurane and O2 for maintenance 
of anaesthesia). Using the Vevo770 imaging system equipped with a 30-MHz linear array transducer 
(VisualSonics Inc, Toronto, Canada), a two-dimensional short-axis view of the left ventricle was obtained 
at the level of the papillary muscles and 2D M-mode tracings were recorded. Left ventricular ejection frac-
tion and fractional shortening were calculated using the following formulas: LVEF% = (LVvol;d-LVvol;s)/
(LVvol;d)*100; LVFS% = (LVID;d-LVID;s)/(LVID;d)*100.
Transverse aortic constriction (TAC). TAC surgeries and subsequent cardiac function assessment 
was performed as described previously47. In brief, TAC was performed in WT or Nur77-KO mice. The 
procedure was performed under isoflurane anaesthesia (4% isoflurane for induction, 2.5% isoflurane and 
O2 for maintenance of anaesthesia) with subcutaneously-injected Buprenorphine (0.05 mg/kg) as local 
and post-operative analgetic. After 28 days, 2D M-mode echocardiography (Aloka SSD 4000 echo device, 
Gene Forward Reverse
acta1 Mus musculus GGCCCCTCCATTGTGCACCG GCCACCCTGCAACCACAGCA
adra1 Mus musculus CGGTCATCCTGGTCATGTACT TACAATGCCCAAGGTTTTGGC
adrb1 Mus musculus CTCATCGTGGTGGGTAACGTG ACACACAGCACATCTACCGAA
adrb2 Mus musculus GAGCACAAAGCCCTCAAGAC GTTGACGTAGCCCAACCAGT
anp Mus musculus ATCACCCTGGGCTTCTTCCT TGTTGGACACCGCACTGTAC
bnp Mus musculus GAGGTCACTCCTATCCTCTGG GCCATTTCCTCCGACTTTTCTC
cacnb2 Mus musculus GTCCTTGACGCGGATACAAT CAGCTGCTACCATCTGGACA
myh7 Mus musculus ACTGTCAACACTAAGAGGGTCA TTGGATGATTTGATCTTCCAGGG
ncx Mus musculus CGAGACTGTGTCGAACCTGA TCAGGGACCACGTAAACACA
nr4a1 Rattus norvegicus TGTTGCTAGAGTCCGCCTTT CAGTGATGAGGACCAGAGCA
nr4a2 Rattus norvegicus CCCAGTGGAGGGTAAACTCA AATGCAGGAGAAGGCAGAAA
nr4a3 Rattus norvegicus TCGCTTCCACATACAAGTGC AAGGGTTCTACAGGGCAGGT
p0 Mus musculus GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG
p0 Rattus norvegicus CTCAGTGCCTCACTCCATCA CTTCCTTTGCTTCGACCTTG
plb Mus musculus CCTTCCTGGCATAATGGAAA ATGCAGATCAGCAGCAGACA
pmca1 Mus musculus GATCCTCTTGTCGGTGGTGT CCGTACTTCACTTGGGCAAT
rpl13a Mus musculus GGGCAGGTTCTGGTATTGGAT GGCTCGGAAGTGGTAGGGG
rpl13a Rattus norvegicus AAAAAGGAGAAGGCCAGAGC CCGCGCATTATTTCTTCTTC
ryr2 Mus musculus GCGAGCTGGCTACTATGACC CGTTGCTAATGCTCACGAAA
serca2a Mus musculus TGTGTAATGCCCTCAACAGC AGCGGTGTGATCTGGAAAAT
Table 1.  Primer sequences. acta1: α 1 skeletal actin; adra1: α 1-adrenergic receptor; adrb1: β 1-adrenergic 
receptor; adrb2: β 2-adrenergic receptor; anp: atrial natriuretic peptide; bnp: brain natriuretic peptide; cacnb2: 
l-type Ca2+ channel, β 2; myh7: β -myosin heavy chain; ncx: Na+/Ca2+ exchanger; nr4a1: Nur77; nr4a2: 
Nurr1; nr4a3; NOR-1; p0: ribosomal protein p0; plb: phospholamban; pmca: plasma membrane Ca2+ ATPase; 
rpl13a: ribosomal protein l13; ryr2: ryanodine receptor 2; serca2a: sarco/endoplasmic Ca2+ ATPase.
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12 MHz transducer; Aloka, Tokyo, Japan) was performed under isoflurane anaesthesia, where after the 
mice were euthanized by 100% CO2 ventilation.
Histological analysis. Ventricles were fixed in 4% formaldehyde for 24 h, embedded in paraffin, sec-
tioned (7 μ m) and mounted on Starfrost glass slides (Thermo Scientific). Nur77 protein expression was 
assessed by immunohistochemistry using anti-Nur77 antibody (Santa Cruz) and anti-rabbit-IgG-HRP 
polymer (BrightVision, ImmunoLogic, Duiven, The Netherlands). Antigen detection was performed by 
development with diaminobenzidine tetrachloride (DAB; Immunologic) and slides were imaged using 
Leica QWin V3 software (Leica Mircosystems, Cambridge, UK).
To assess cardiomyocyte cross-sectional area, cardiac tissue was stained with AlexaFluor488-conjugated 
wheat germ agglutinin (Molecular Probes, Eugene, OR, USA) and DAPI. Cardiomyocytes were included 
in size measurement if they were transversely cross-sectioned and revealed thin, intact cell borders and 
visible nuclei located in proximity of the cell centre. Per mouse, ≥ 75 cardiomyocytes were measured 
using ImageJ software to acquire a proper representation of the tissue. Collagen quantification was per-
formed on Masson’s Trichrome-stained (Sigma-Aldrich) sections, using Leica QWin V3 software.
Apoptotic cells were assessed by TUNEL assay using the In Situ Cell Death Detection Kit (Roche, 
Indianapolis, IN, USA) according to manufacturer’s instructions and quantified as number of TUNEL+ 
cells by fluorescence microscopy.
RNA isolation and real time-PCR. Total RNA was isolated from NRVMs using the Aurum Total 
RNA mini kit (BioRad Laboratories, Veenendaal, The Netherlands) and total RNA from cardiac tissue 
was isolated using the RNeasy Fibrous Tissue Mini kit (Qiagen, Frederick, MD, USA), all according to 
manufacturer’s instructions. cDNA was synthesized with the iScript cDNA Synthesis kit and real-time 
PCR was performed using iQ SYBR Green Supermix and was measured with the MyIQ system (all from 
BioRad). Specific primer sequences are listed in Table 1. mRNA levels were normalized for the combined 
value of ribosomal protein P0 (p0) and ribosomal protein L13 (rpl13) housekeeping genes.
Calcineurin activity assay. Protein was isolated from snap-frozen murine left ventricles using 
lysis buffer supplied in the calcineurin activity assay kit (Enzo Life Sciences, Exeter, UK). Calcineurin 
phosphatase activity was measured in 5 ug protein from each lysate, according to the manufacturer’s 
instructions.
Statistical analysis. All data analyses were performed using GraphPad Prism 5 (La Jolla, CA, USA). 
Data distribution was tested with Kolmogorov-Smirnov normality test. Accordingly, data is presented as 
mean ± SEM and tested with Student’s t-test, two-way repeated measures ANOVA or Fisher’s exact test. 
In case of a failed normality test, data is presented as boxplots with whiskers for minimum/maximum 
values and tested with Mann-Whitney-U test. Holm-Bonferonni or Newman-Keuls test post-hoc cor-
rection was used when appropriate.
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